Market Research Logo

US Market for Peripheral Vascular Stents and Stent Grafts - MedCore

Restenosis is a re-narrowing of the treated blood vessel and leads to decreased blood flow. It is commonly attributed to intimal hyperplasia at the site of the stenting procedure. For this reason, technological innovations, such as covered stents, which physically block cellular intrusion from neointimal hyperplasia (NIHA), have already become commercialized.

Restenosis rates for PTA balloon catheters range from 10% to 12% in the iliac to 40% in the superficial femoral-popliteal arteries. Additionally, there is clinical evidence supporting the use of drug-eluting stents to combat these complications; however, incomplete endothelialization of the stent struts is leading to a reassessment of their efficacy.

Abdominal aortic aneurysm (AAA) is the thirteenth-leading cause of death in the U.S. and a leading cause of death for American men over the age of 65. The most common location for aortic aneurysms is in the abdominal aorta. The rest occur in the thoracic area. As a result, most AAAs are located below the level of the renal arteries, and approximately 20 to 30% extend into one or both of the iliac arteries.

Once an AAA develops, it begins to enlarge, increasing the likelihood of rupture. Left untreated, approximately one-third of AAAs will eventually rupture. When this occurs, internal bleeding causes most patients to die out of hospital or before surgery. Only 10% to 25% of patients who experience an AAA rupture survive to hospital discharge.


EXECUTIVE SUMMARY
1.1 PERIPHERAL VASCULAR STENT MARKET
1.2 STENT GRAFT MARKET
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
PERIPHERAL VASCULAR STENT MARKET
3.1 INTRODUCTION
3.1.1 Off-Label Use
3.1.2 Covered Stents
3.1.3 Drug-Eluting Peripheral Vascular Stents
3.1.4 Infrapopliteal Stenting
3.1.5 Stent Length
3.1.6 General Information
3.2 MARKET OVERVIEW
3.3 MARKET ANALYSIS AND FORECAST
3.3.1 Total Peripheral Vascular Stent Market
3.3.2 Total Bare-Metal Peripheral Vascular Stent Market
3.3.2.1 Bare-Metal Peripheral Vascular Stent Market by Indication
3.3.2.1.1 Iliac Bare-Metal Stent Market
3.3.2.1.2 Femoral Popliteal Bare-Metal Stent Market
3.3.2.1.3 Renal Bare-Metal Stent Market
3.3.2.1.4 Carotid Bare-Metal Stent Market
3.3.3 Covered Peripheral Vascular Stent Market
3.4 UNIT ANALYSIS
3.4.1 Bare-Metal Stent Units Sold by Stent Length
3.4.1.1 Iliac Bare-Metal Stent Units Sold by Stent Length
3.4.1.2 Femoral-popliteal Bare-Metal Stent Units Sold by Stent Length
3.4.1.3 Renal Bare-Metal Stent Units Sold by Stent Length
3.4.1.4 Carotid Bare-Metal Stent Units Sold by Stent Length
3.4.2 Bare-Metal Stent Units Sold by Delivery Platform
3.5 DRIVERS AND LIMITERS
3.5.1 Market Drivers
3.5.2 Market Limiters
3.6 COMPETITIVE ANALYSIS
3.6.1 Total Peripheral Vascular Stent Market
3.6.2 Bare-Metal Stent Market by Indication
3.6.2.1.1 Iliac
3.6.2.1.2 Carotid
3.6.2.1.3 Renal
3.6.2.1.4 Femoral-Popliteal
3.6.3 Bare-Metal Stent Market by Delivery Platform
STENT GRAFT MARKET
4.1 INTRODUCTION
4.2 MARKET OVERVIEW
4.3 MARKET ANALYSIS AND FORECAST
4.3.1 Total Stent Graft Market
4.3.2 Abdominal Aortic Aneurysm Stent Graft Market
4.3.3 Thoracic Aortic Aneurysm Stent Graft Market
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE ANALYSIS
ABBREVIATIONS
List of Charts
Chart 1 1: Peripheral Vascular Stent Market by Segment, U.S., 2014 – 2017 1
Chart 1 2: Procedure Growth Rates by Segment, Stent Graft Market, U.S., 2014 – 2017 2
Chart 3 1: Peripheral Vascular Stent Market by Segment, U.S., 2012 – 2022 21
Chart 3 2: Peripheral Vascular Stent Market Breakdown, U.S., 2015 22
Chart 3 3: Peripheral Vascular Stent Market Breakdown, U.S., 2022 22
Chart 3 4: Total Peripheral Vascular Stent Market, U.S., 2012 – 2022 24
Chart 3 5: Total Bare-Metal Peripheral Vascular Stent Market, U.S., 2012 – 2022 26
Chart 3 6: Bare-Metal Peripheral Vascular Stent Market by Indication, U.S., 2012 – 2022 29
Chart 3 7: Iliac Bare-Metal Stent Market, U.S., 2012 – 2022 30
Chart 3 8: Femoral Popliteal Bare-Metal Stent Market, U.S., 2012 – 2022 31
Chart 3 9: Renal Bare-Metal Stent Market, U.S., 2012 – 2022 32
Chart 3 10: Carotid Bare-Metal Stent Market, U.S., 2012 – 2022 33
Chart 3 11: Covered Peripheral Vascular Stent Market, U.S., 2012 – 2022 35
Chart 3 12: Iliac Bare-Metal Stent Units Sold by Stent Length, U.S., 2012 – 2022 38
Chart 3 13: Femoral-popliteal Bare-Metal Stent Units Sold by Stent Length, U.S., 2012 – 2022 39
Chart 3 14: Renal Bare-Metal Stent Units Sold by Stent Length, U.S., 2012 – 2022 40
Chart 3 15: Carotid Bare-Metal Stent Units Sold by Stent Length, U.S., 2012 – 2022 41
Chart 3 16: Bare-Metal Stent Units Sold by Delivery Platform, U.S., 2012 – 2022 43
Chart 3 17: Leading Competitors, Peripheral Vascular Stent Market, U.S., 2015 50
Chart 3 18: Leading Competitors, Bare-Metal Stent Market, U.S., 2015 53
Chart 3 19: Leading Competitors, Bare-Metal Stent Market by Delivery Platform, U.S., 2015 55
Chart 4 1: Stent Graft Market by Segment, U.S., 2012 – 2022 59
Chart 4 2: Stent Graft Market Breakdown, U.S., 2015 60
Chart 4 3: Stent Graft Market Breakdown, U.S., 2022 60
Chart 4 4: Total Stent Graft Market, U.S., 2012 – 2022 62
Chart 4 5: Abdominal Aortic Aneurysm Stent Graft Market, U.S., 2012 – 2022 64
Chart 4 6: Thoracic Aortic Aneurysm Stent Graft Market, U.S., 2012 – 2022 66
Chart 4 7: Leading Competitors, Stent Graft Market, U.S., 2015 72
List of Figures
Figure 3 1: General Information, Peripheral Vascular Stent Market, U.S., 2015 19
Figure 3 2: Peripheral Vascular Stent Market by Segment, U.S., 2012 – 2022 (US$M) 20
Figure 3 3: Total Peripheral Vascular Stent Market, U.S., 2012 – 2022 23
Figure 3 4: Total Bare-Metal Peripheral Vascular Stent Market, U.S., 2012 – 2022 25
Figure 3 5: Bare-Metal Peripheral Vascular Stent Market by Indication, U.S., 2012 – 2022 (US$M) 28
Figure 3 6: Iliac Bare-Metal Stent Market, U.S., 2012 – 2022 30
Figure 3 7: Femoral Popliteal Bare-Metal Stent Market, U.S., 2012 – 2022 31
Figure 3 8: Renal Bare-Metal Stent Market, U.S., 2012 – 2022 32
Figure 3 9: Carotid Bare-Metal Stent Market, U.S., 2012 – 2022 33
Figure 3 10: Covered Peripheral Vascular Stent Market, U.S., 2012 – 2022 34
Figure 3 11: Iliac Bare-Metal Stent Units Sold by Stent Length, U.S., 2012 – 2022 38
Figure 3 12: Femoral-popliteal Bare-Metal Stent Units Sold by Stent Length, U.S., 2012 – 2022 39
Figure 3 13: Renal Bare-Metal Stent Units Sold by Stent Length, U.S., 2012 – 2022 40
Figure 3 14: Carotid Bare-Metal Stent Units Sold by Stent Length, U.S., 2012 – 2022 41
Figure 3 15: Bare-Metal Stent Units Sold by Delivery Platform, U.S., 2012 – 2022 42
Figure 3 16: Drivers and Limiters, Peripheral Vascular Stent Market, U.S., 2015 47
Figure 3 17: Leading Competitors, Peripheral Vascular Stent Market, U.S., 2015 50
Figure 3 18: Leading Competitors, Bare-Metal Stent Market, U.S., 2015 53
Figure 3 19: Leading Competitors, Bare-Metal Stent Market by Delivery Platform, U.S, 2015 54
Figure 4 1: Stent Graft Market by Segment, U.S., 2012 – 2022 (US$M) 58
Figure 4 2: Total Stent Graft Market, U.S., 2012 – 2022 61
Figure 4 3: Abdominal Aortic Aneurysm Stent Graft Market, U.S., 2012 – 2022 63
Figure 4 4: Thoracic Aortic Aneurysm Stent Graft Market, U.S., 2012 – 2022 65
Figure 4 5: Drivers and Limiters, Stent Graft Market, U.S., 2015 69
Figure 4 6: Leading Competitors, Stent Graft Market, U.S., 2015 72

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report